Form D · Biotechnology
LAZURE SCIENTIFIC INC
Issaquah, WA · CIK 0001393762
Offering snapshot reported Nov 2, 2011 · SEC filing
- Reported sold
- $3.15M Offering amount: $6M
- Investors reported
- 23 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Oct 21, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 2, 2011 | Initial | $3,146,590 | No comparison | 23 | SEC filing |
| Apr 7, 2010 | Initial | $2,014,005 | No comparison | 16 | SEC filing |
| Mar 14, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-168121
Source: Form D, filed Nov 2, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Armstrong | Director |
| Leo Azure | Director |
| Perry Di Loreto | Director |
| Charles Hill | Director, Executive |
| Paul Lange | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1315 Nw Mall Street Suite 2
Issaquah, WA, 98027
Issaquah, WA, 98027